Modifications

===== Detection Of Anti-XMRV Antibodies In Serum of CFS Patients and Healthy Blood Donors in Belgium =====

===== Detection Of Anti-XMRV Antibodies In Serum of CFS Patients and Healthy Blood Donors in Belgium =====

Kenny De Meirleir, M.D. Son exposé concerne une étude où on retrouve deux auteurs de l'étude ci-dessus (Vincent C. Lombardi et Judy A. Mikovits). Il semblerait qu'il ait participé à l'étude puisque aucun des autres auteurs n'est affilié à l'Université libre de Bruxelles et qu'il en faisait partie.

Kenny De Meirleir, M.D. Son exposé concerne une étude où on retrouve deux auteurs de l'étude ci-dessus (Vincent C. Lombardi et [[Judy Mikovits|Judy A. Mikovits]]). Il semblerait qu'il ait participé à l'étude puisque aucun des autres auteurs n'est affilié à l'Université libre de Bruxelles et qu'il en faisait partie.

Marc Frémont², Svetlana Khaliboulina³, Vincent C. Lombardi³, Cassandra Puccinelli³, Kristine Metzger², Judy A. Mikovits³<br>

Marc Frémont², Svetlana Khaliboulina³, Vincent C. Lombardi³, Cassandra Puccinelli³, Kristine Metzger², [[Judy Mikovits|Judy A. Mikovits]]³<br>

1. Department of Human Physiology, Vrije Universiteit Brussel, Brussels, Belgium<br>

1. Department of Human Physiology, Vrije Universiteit Brussel, Brussels, Belgium<br>

2. RED Laboratories, Zellik, Belgium<br>

2. RED Laboratories, Zellik, Belgium<br>

3. Whittemore Peterson Institute, Reno, Nevada, USA

3. Whittemore Peterson Institute, Reno, Nevada, USA

Objectives:<br>

Objectives:<br>

Xenotropic murine leukemia virus–related virus (XMRV) is a new human gammaretrovirus originally identified in prostate cancer patients with a deficiency in the antiviral enzyme RNase L. An association has been made between XMRV and Chronic Fatigue Syndrome (CFS), with a 2009 study reporting the presence of XMRV DNA in the blood of 67% of CFS patients, whereas only 3,7% of healthy controls tested positive. In 2010 another study detected murine leukemia virus (MLV)-like GAG sequences in 86,5% of CFS patients, versus only 6,8% of healthy blood donors. A number of other studies, however, have failed to detect XMRV DNA in the blood of CFS patients. The objectives of this study were to investigate the association between CFS and XMRV in a Belgian population of patients, and to estimate the prevalence of XMRV infections in the general population in Belgium.

Xenotropic murine leukemia virus–related virus (XMRV) is a new human gammaretrovirus originally identified in prostate cancer patients with a deficiency in the antiviral enzyme RNase L. An association has been made between XMRV and Chronic Fatigue Syndrome (CFS), with a 2009 study reporting the presence of XMRV DNA in the blood of 67% of CFS patients, whereas only 3,7% of healthy controls tested positive. In 2010 another study detected murine leukemia virus (MLV)-like GAG sequences in 86,5% of CFS patients, versus only 6,8% of healthy blood donors. A number of other studies, however, have failed to detect XMRV DNA in the blood of CFS patients. The objectives of this study were to investigate the association between CFS and XMRV in a Belgian population of patients, and to estimate the prevalence of XMRV infections in the general population in Belgium.